封面
市场调查报告书
商品编码
1512677

全球链球菌益生菌市场 - 2024-2031

Global Streptococcus Probiotic Market - 2024-2031

出版日期: | 出版商: DataM Intelligence | 英文 213 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2023年,全球链球菌益生菌市场达到6.231亿美元,预计2031年将达到9.431亿美元,2024-2031年预测期间复合年增长率为6.1%。

人们对肠道健康及其与整体健康的连结的认识不断增强,正在推动全球链球菌益生菌市场的发展。消费者越来越了解益生菌(包括链球菌菌株)在改善消化、增强免疫力和增强整体健康方面的益处。这一趋势正在推动市场对高品质益生菌产品的需求。

益生菌配方和递送方法的持续创新是链球菌益生菌市场的重要趋势。例如,2022 年 9 月 26 日,纽西兰益生菌公司 Blis 宣布了有关上呼吸道健康的可喜结果。凭藉最近的有利发现,该公司正在扩大其旗舰益生菌菌株 BLIS K12 的潜在健康益处,特别关注上呼吸道健康。

亚太地区的消费者健康意识日益增强,对包括链球菌菌株在内的益生菌的益处有了更多认识。这种健康意识的提高推动了对益生菌产品的需求,将其作为日常饮食的一部分,以改善消化健康和增强免疫力。消费者对健康和预防性健康的日益关注正在扩大链球菌益生菌的市场。

动力学

个性化营养的成长趋势

随着消费者越来越了解肠道健康的重要性和益生菌的益处,对根据个人健康需求量身定制的个人化益生菌解决方案的需求不断增长。链球菌益生菌以其潜在的健康益处而闻名,并且能够很好地利用这一趋势。市场成长是由消费者寻求解决特定健康问题或饮食偏好的益生菌产品所推动的,从而有助于增加销售和市场扩张。

随着对微生物组的科学认识不断加深,人们对链球菌益生菌的功效和安全性的信心不断增强,从而推动了全球市场上消费者的信任和采用。例如,2023 年 3 月 28 日,Bailey 强调了针对 IBS 的嗜热链球菌益生菌菌株在蓬勃发展的生物製品市场中的显着特征:即使在高发炎条件下也能蓬勃发展。

益生菌产品的持续创新

链球菌益生菌产品的创新包括配方、输送系统和功能方面的进步,提供了使其在市场上脱颖而出的差异化功能。益生菌菌株稳定性、生物利用度和生存能力的增强可提高产品功效和消费者满意度,从而推动市场采用和忠诚度。创新的产品功能满足特定消费者的需求和偏好,推动市场差异化和竞争力。

根据国际益生菌协会的说法,儘管嗜热链球菌的名字可能令人震惊,但它可以被比作微生物群中温暖和养育的婆婆。嗜热链球菌不是有害菌株;事实上,他们消费它的频率比他们想像的要高!许多嗜热链球菌菌株都是友善的益生菌,其特点是温暖和滋养特性。作为一种革兰氏阳性乳酸益生菌,嗜热链球菌在其喜爱的一些食品(包括优格)的生产中发挥关键作用。

缺乏消费者意识

消费者对链球菌益生菌及其健康益处认识不足的一个主要后果是需求减少。消费者不了解这些益生菌的具体优势,例如它们在改善消化健康和增强免疫力方面的作用,他们不太可能寻找或购买这些产品。这种有限的需求直接影响市场的整体规模和成长。

缺乏认识也会影响链球菌益生菌在市场上的认知价值。与较知名的益生菌或保健补充剂相比,不熟悉具体益处的消费者认为这些产品的重要性或附加价值较低。这种看法可能会导致定价压力,因为公司被迫降低价格来吸引消费者,这可能会影响市场获利能力和投资进一步创新的能力。

目录

第 1 章:方法与范围

第 2 章:定义与概述

第 3 章:执行摘要

第 4 章:动力学

  • 影响因素
    • 司机
      • 个性化营养的成长趋势
      • 益生菌产品的持续创新
    • 限制
      • 缺乏消费者意识
    • 机会
    • 影响分析

第 5 章:产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 俄乌战争影响分析
  • DMI 意见

第 6 章:COVID-19 分析

第 7 章:按类型

  • 唾液链球菌
  • 嗜热链球菌
  • 其他的

第 8 章:按申请

  • 功能性食品和饮料
  • 膳食补充剂
  • 动物饲料
  • 其他的

第 9 章:最终用户

  • 人类
  • 动物

第 10 章:按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 俄罗斯
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 亚太其他地区
  • 中东和非洲

第 11 章:竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 12 章:公司简介

  • Mitushi Bio Pharma
    • 公司简介
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Probi AB
  • Alpspure Lifesciences Pvt. Ltd.
  • Fido Pharma Pvt. Ltd.
  • Probiotics International Ltd (Protexin)
  • Jaipur Bio Fertilizers
  • Advanced Vital Enzymes Private Ltd (Advenza)
  • Fengchen Group Co., Ltd
  • Biodep Biotechnology Co., Ltd
  • Probioway Co., Ltd

第 13 章:附录

简介目录
Product Code: FB8528

Overview

Global Streptococcus Probiotic Market reached US$ 623.1 million in 2023 and is expected to reach US$ 943.1 million by 2031, growing with a CAGR of 6.1% during the forecast period 2024-2031.

The increasing awareness of gut health and its connection to overall wellness is driving the global Streptococcus probiotic market. Consumers are becoming more informed about the benefits of probiotics, including Streptococcus strains, for improving digestion, boosting immunity, and enhancing overall health. This trend is propelling the demand for high-quality probiotic products in the market.

Continued innovation in probiotic formulations and delivery methods is a significant trend in the Streptococcus probiotic market. For instance, on September 26, 2022, Blis, a probiotic company based in New Zealand, announced promising results regarding upper respiratory health. With recent favorable findings, the company is expanding the potential health benefits associated with its flagship probiotic strain, BLIS K12, particularly focusing on upper respiratory well-being.

Consumers in the Asia-Pacific region are becoming more health-conscious, leading to a greater awareness of the benefits of probiotics, including Streptococcus strains. This heightened health awareness is driving demand for probiotic products as part of daily dietary routines to improve digestive health and boost immunity. The growing consumer focus on wellness and preventive health is expanding the market for Streptococcus probiotics.

Dynamics

Growing Trend Towards Personalized Nutrition

As consumers become more knowledgeable about the importance of gut health and the benefits of probiotics, there is a growing demand for personalized probiotic solutions tailored to individual health needs. Streptococcus probiotics, known for their potential health benefits, are well-positioned to capitalize on this trend. Market growth is driven by consumers seeking probiotic products that address specific health concerns or dietary preferences, contributing to increased sales and market expansion.

As scientific understanding of the microbiome expands, there is increased confidence in the efficacy and safety of Streptococcus probiotics, driving consumer trust and adoption in the global market. For instance, on March 28, 2023, Bailey highlighted the distinctive feature of the IBS-targeted Streptococcus thermophilus probiotic strain in the thriving biotics market: its ability to thrive even in high-inflammatory conditions.

Continued Innovation in Probiotic Products

Innovation in Streptococcus probiotic products encompasses advancements in formulation, delivery systems, and functionality, offering differentiated features that set them apart in the market. Enhanced stability, bioavailability, and survivability of probiotic strains improve product efficacy and consumer satisfaction, driving market adoption and loyalty. Innovative product features address specific consumer needs and preferences, driving market differentiation and competitiveness.

According to the International Probiotic Association, Despite its potentially alarming name, Streptococcus thermophilus could be likened to the warm and nurturing mother-in-law of their microbiome. Streptococcus thermophilus isn't a harmful strain; in fact, they consume it more frequently than they might think! Many strains of Streptococcus thermophilus are friendly probiotics, characterized by their warmth and nurturing properties. As a gram-positive, lactic-acid probiotic, Streptococcus thermophilus plays a key role in the production of some of their favorite foods, including yogurt.

Lack of Consumer Awareness

A primary consequence of low consumer awareness about Streptococcus probiotics and their health benefits is reduced demand. Consumers are not knowledgeable about the specific advantages of these probiotics, such as their role in improving digestive health and boosting immunity, they are less likely to seek out or purchase these products. This limited demand directly impacts the overall size and growth of the market.

Lack of awareness can also affect the perceived value of Streptococcus probiotics in the market. Consumers unfamiliar with the specific benefits view these products as less essential or value-added compared to more well-known probiotics or health supplements. This perception can lead to pricing pressures, as companies are forced to lower prices to attract consumers, potentially affecting market profitability and the ability to invest in further innovation.

Segment Analysis

The global streptococcus probiotic market is segmented based on type, application, end-user, and region.

Growing Consumer Preference for Functional Foods

Streptococcus thermophilus is extensively used in the production of dairy products like yogurt and cheese, which are popular across various regions. The high consumption of these dairy products contributes significantly to the market share of Streptococcus thermophilus probiotics. Their established presence in everyday food items ensures a steady demand in the segment market.

Continuous innovation and product development in the probiotic market are centered around creating more effective and consumer-friendly probiotic products. Streptococcus thermophilus, being a well-studied and versatile strain, is frequently used in these new formulations. The ongoing development of innovative products containing this strain drives market growth and secures its leading position.

Geographical Penetration

High Consumer Demand and Investments in Asia-Pacific

The Asia-Pacific region has a large and growing population with increasing health awareness. Consumers are increasingly seeking probiotic products to improve digestive health, boost immunity, and enhance overall well-being. This high consumer demand is driving the market for Streptococcus probiotics, contributing to the region's dominant position in the global streptococcus probiotic market.

Significant investments in research and development are leading to innovations in the Streptococcus probiotic market. Asia-Pacific countries like Japan and South Korea are at the forefront of scientific research in probiotics, leading to new product developments and improved formulations. This focus on innovation attracts consumers and boosts streptococcus probiotic market growth.

COVID-19 Impact Analysis

The pandemic caused widespread disruptions to global supply chains, affecting the production and distribution of probiotics. Manufacturing plants faced challenges such as labor shortages, transportation delays, and raw material shortages. These disruptions impacted the availability of Streptococcus probiotic products in the market, leading to potential shortages and increased production costs. Companies had to adapt by finding alternative supply chain solutions to maintain market stability.

The pandemic underscored the need for scientific research and innovation in health products. The Streptococcus probiotic market has seen increased investment in research and development to better understand the health benefits of these probiotics and to develop new, effective formulations. This focus on R&D has driven innovation, resulting in a broader range of high-quality products entering the market.

Russia-Ukraine War Impact Analysis

The conflict has disrupted global supply chains, affecting the availability of raw materials and ingredients necessary for the production of Streptococcus probiotics. With key transportation routes and logistics hubs in the affected regions, the war has caused delays and increased costs in shipping and logistics. These disruptions have impacted the market by limiting product availability and increasing production costs.

The war has led to increased prices for raw materials and energy, which are essential for manufacturing probiotic products. Higher costs for ingredients, packaging, and transportation have forced producers to adjust their pricing strategies. This escalation in production costs is reflected in the market as higher prices for Streptococcus probiotic products could potentially limit consumer access and affordability.

By Type

  • Streptococcus Salivarius
  • Streptococcus Thermophilus
  • Others

By Application

  • Functional Food & Beverages
  • Dietary Supplements
  • Animal Feed
  • Others

By End-User

  • Human
  • Animal

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • On November 21, 2023, Designs for Health, Inc., a dietary supplement and functional food company, introduced PerioBiotic Silver, a new probiotic toothpaste aimed at promoting oral microbiome health. This fluoride-free product promises to revolutionize the oral healthcare industry with its microbiome-safe formulation. PerioBiotic Silver features a unique blend of ingredients such as purified silver, CoQ10, and grape seed extract, all designed to support balanced oral and dental wellness.
  • On April 18, 2023, The Indonesian food safety authority introduced stringent standards to regulate the presence of microorganisms, including probiotics, in general, processed foods and beverages like yogurt and kombucha. With the rising consumer interest in fermented foods that offer potential health benefits, such as probiotics for immune support, these new regulations aim to ensure safety and quality. This trend is particularly notable in Southeast Asian countries, including Indonesia.
  • On April 17, 2024, In a groundbreaking development, Hillman engineered a strain of dental plaque bacteria to metabolize sugar differently, producing Lactic acid instead of alcohol. This innovation aims to prevent tooth decay by addressing the root cause, offering a promising solution to combat cavity-causing bacteria.

Competitive Landscape

The major global players in the global streptococcus probiotic market include Mitushi Bio Pharma, Probi AB, Alpspure Lifesciences Pvt. Ltd., Fido Pharma Pvt. Ltd., Probiotics International Ltd (Protexin), Jaipur Bio Fertilizers, Advanced Vital Enzymes Private Ltd (Advenza), Fengchen Group Co., Ltd, Biodep Biotechnology Co., Ltd, and Probioway Co., Ltd.

Why Purchase the Report?

  • To visualize the global streptococcus probiotic market segmentation based on type, application, end-user, and region, as well as understand critical commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous global streptococcus probiotic market-level data points with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of critical products of all the major players.

The global streptococcus probiotic market report would provide approximately 70 tables, 68 figures, and 213 users.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End-User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing Trend Towards Personalized Nutrition
      • 4.1.1.2. Continued Innovation in Probiotic Products
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of Consumer Awareness
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Streptococcus Salivarius*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Streptococcus Thermophilus
  • 7.4. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Functional Food & Beverages*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Dietary Supplements
  • 8.4. Animal Feed
  • 8.5. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Human*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Animal

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Russia
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Mitushi Bio Pharma*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Probi AB
  • 12.3. Alpspure Lifesciences Pvt. Ltd.
  • 12.4. Fido Pharma Pvt. Ltd.
  • 12.5. Probiotics International Ltd (Protexin)
  • 12.6. Jaipur Bio Fertilizers
  • 12.7. Advanced Vital Enzymes Private Ltd (Advenza)
  • 12.8. Fengchen Group Co., Ltd
  • 12.9. Biodep Biotechnology Co., Ltd
  • 12.10. Probioway Co., Ltd

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us